Fig. 3From: Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumabRates of Juvenile Disease Activity Score (JADAS)10 remission and minimal disease activity in patients taking etanercept, adalimumab or tocilizumabBack to article page